MolNFT v1 · #171679 · protein
Syk kinase domain in complex with azabenzimidazole inhibitor 18
6ZCX · Tyrosine-protein kinase syk: “Syk kinase domain in complex with azabenzimidazole inhibitor 18”. X-ray diffraction, 1 ligand (QFQ), 2 pockets (best druggability 0.57). MolNFT v1 #171679 on GenesisL1: 3D structure, binding sites and…
- PDB
- 6ZCX
- Type
- protein
- Length
- 266 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tyrosine-protein kinase syk
- EC
- 2.7.10.2
- UniProt
- P43405
- Ligands
- QFQ
- Pockets
- 2 · best druggability 0.57
Structure
x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tyrosine-protein kinase syk (EC 2.7.10.2) | protein | 266 | 41% helix, 21% strand | P43405 |
Ligands and binding sites
- QFQ · ~{N},1-dimethyl-5-[[4-[3-methyl-4-[[(3~{R})-piperidin-3-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]indazole-3-carboxamide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 243 | 0.57 | 0.78 | 35 | QFQ |
| 2 | 60 | 0.29 | 0.74 | 14 | empty |
Compared structures
- 6ZCX · SYK Kinase domain in complex with azabenzimidazole inhibitor 18 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P43405
- Elsewhere: RCSB PDB 6ZCX · PDBe 6ZCX · UniProt P43405
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.